Prokinétiques chez le patient de réanimation: quand et lesquels ? = Promotility agents during critical illness: which drug and when to administer?DIVE, A.-M.Réanimation (Paris. 2001). 2011, Vol 20, Num 4, pp 319-326, issn 1624-0693, 8 p.Article

Relaxations transitoires du sphincter inférieur de l'oesophage et traitement du reflux gastro-oesophagienDIALLO, Abdourhamane D; BRULEY DES VARANNES, Stanislas.Hépato-gastro (Montrouge). 2005, Vol 12, Num 6, pp 403-407, issn 1253-7020, 5 p.Article

Prokinetic agents in childen with poor appetiteBEKEM, O; BUYUKGEBIZ, B; AYDIN, A et al.Acta gastro-enterologica belgica (English ed.). 2005, Vol 68, Num 4, pp 416-418, issn 1784-3227, 3 p.Article

How inverse can a neutral antagonist be? Strategic questions after the rimonabant issueGIRALDO, Jesús.Drug discovery today. 2010, Vol 15, Num 11-12, pp 411-415, issn 1359-6446, 5 p.Article

Prokinetic effect of gut-oriented hypnosis on gastric emptyingCHIARIONI, G; VANTINI, I; DE IORIO, F et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 8, pp 1241-1249, issn 0269-2813, 9 p.Article

The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentrationJONES, K. L; KONG, M.-F; BERRY, M. K et al.The American journal of gastroenterology. 1999, Vol 94, Num 8, pp 2074-2079, issn 0002-9270Article

Erythromycin and other macrolides as prokinetic agentsPEETERS, T. L.Gastroenterology (New York, NY. 1943). 1993, Vol 105, Num 6, pp 1886-1899, issn 0016-5085Article

Facteurs de risque de l'utilisation de l'érythromycine comme agent prokinétique = Erythromycin as a prokinetic agent: Risk factorsBERTHET, S; CHARPIAT, B; MABRUT, J. Y et al.Journal de chirurgie viscérale (Print). 2010, Vol 147, Num 2, pp 100-105, issn 1878-786X, 6 p.Article

Traitement du reflux gastro-œsophagien: de l'abstention thérapeutique à la chirurgie = Gastroesophageal reflux treatment: From therapeutic abstention to surgeryTOUNIAN, P.Archives de pédiatrie (Paris). 2009, Vol 16, Num 10, pp 1424-1428, issn 0929-693X, 5 p.Article

Pharmacokinetic and bioequivalence study of itopride HCl in healthy volunteersCHO, Kyung-Jin; CHO, Wonkyung; CHA, Kwang-Ho et al.Arzneimittel-Forschung. 2010, Vol 60, Num 3, pp 137-140, issn 0004-4172, 4 p.Article

Effectiveness of prokinetic agents against diseases external to the gastrointestinal tractHIYAMA, Toru; YOSHIHARA, Masaharu; TANAKA, Shinji et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 4, pp 537-546, issn 0815-9319, 10 p.Article

The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazoleROBERT, Marta; SALVA, Miquel; SEGARRA, Rosa et al.Drug metabolism and disposition. 2007, Vol 35, Num 7, pp 1149-1156, issn 0090-9556, 8 p.Article

L'administration de prokinétiques au cours d'une alimentation entérale : utilité et limites = Use of prokinetic drugs during enteral nutrition : usefulness and limitationsDIVE, A.Réanimation (Paris. 2001). 2001, Vol 10, Num 6, pp 562-569, issn 1624-0693Article

Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection : application to pharmacokinetic studyDESTA, Z; SOUKHOVA, N. V; MOROCHO, A et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 744, Num 2, pp 263-272, issn 1387-2273Article

Unravelling the complex dissociation of [³H]-rimonabant from plated CB₁ cannabinoid receptor-expressing cellsWENNERBERG, M; BALENDRAN, A; CLAPHAM, J. C et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 2, pp 181-187, issn 0767-3981, 7 p.Article

CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant)RAFFA, R. B; WARD, S. J.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 3, pp 260-265, issn 0269-4727, 6 p.Article

Erythromycin induces pyloric relaxation accompanied by a contraction of the gastric body after pylorus-preserving gastrectomyNAKABAYASHI, Toshihiro; MOCHIKI, Erito; KAMIYAMA, Yoichi et al.Surgery. 2003, Vol 133, Num 6, pp 647-655, issn 0039-6060, 9 p.Article

Quality of life in functional dyspepsiaMONES, Joan; ADAN, Ana; SEGU, Jose L et al.Digestive diseases and sciences. 2002, Vol 47, Num 1, pp 20-26, issn 0163-2116Article

Prokinetic agents in the surgical patientTHOMPSON, J. S; QUIGLEY, E. M. M.The American journal of surgery. 1999, Vol 177, Num 6, pp 508-514, issn 0002-9610Article

Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist RimonabantANDRESEN BERGSTRÖM, Moa; ISIN, Emre M; CASTAGNOLI, Neal et al.Drug metabolism and disposition. 2011, Vol 39, Num 10, pp 1823-1832, issn 0090-9556, 10 p.Article

Identification of cytochromes P450 involved in human liver microsomal metabolism of ecabapide, a prokinetic agentFUJIMAKI, Y; ARAI, N; INABA, T et al.Xenobiotica (London. Print). 1999, Vol 29, Num 12, pp 1273-1282, issn 0049-8254Article

Interaction of cisapride with the human cytochrome P450 system : Metabolism and inhibition studiesDESTA, Z; SOUKHOVA, N; MAHAL, S. K et al.Drug metabolism and disposition. 2000, Vol 28, Num 7, pp 789-800, issn 0090-9556Article

Nutrition entérale et stase gastrique : intérêt des procinétiques = Gastroparesis and enteral nutrition : interest in prokineticsMAISONNEUVE, N; KARSEGARD, V. L; GENTON, L et al.Médecine et hygiène. 2001, Vol 59, Num 2349, pp 1269-1271, issn 0025-6749Article

The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsiaBESHERDAS, K; LEAHY, A; MASON, I et al.Alimentary pharmacology & therapeutics. 1998, Vol 12, Num 8, pp 755-759, issn 0269-2813Article

Effect of rimonabant on oesophageal motor function in manSCARPELLINI, E; BLONDEAU, K; BOECXSTAENS, V et al.Alimentary pharmacology & therapeutics. 2011, Vol 33, Num 6, pp 730-737, issn 0269-2813, 8 p.Article